Francisco Veas

Prof. Francisco Veas


Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

1 April 2020 in International Journal of Infectious Diseases
Verified
Journal Article
Open access
NKNathan Kapata
Nathan Kapata
CIChikwe Ihekweazu
Chikwe Ihekweazu
FNFrancine Ntoumi
Francine Ntoumi
TRTajudeen Raji
Tajudeen Raji
PCPascalina Chanda-Kapata
Pascalina Chanda-Kapata
AZAlimuddin Zumla
Alimuddin Zumla

13 May 2011 in Virology Journal
Verified
Journal Article
Open access
PDF file
DMDelphine Marsac
Delphine Marsac
SGStephanie García
Stephanie García
AFAlexandra Fournet
Alexandra Fournet
AAAdam Aguirre
Adam Aguirre
KPKarla Pino
Karla Pino
FVFrancisco Veas
Francisco Veas
Background: Andes virus (ANDV), a rodent-borne Hantavirus, is the major etiological agent of Hantavirus cardiopulmonary syndrome (HCPS) in South America, which is mainly characterized by a vascular leakage with high rate of fatal outcomes for infected patients. Currently, neither specific therapy nor vaccines are available against this pathogen. ANDV infects both dendritic and epithelial cells, but in despite that the severity of the disease directly correlates with the viral RNA load, considerable evidence suggests that immune mechanisms rather than direct viral cytopathology are responsible for plasma leakage in HCPS. Here, we assessed the possible effect of soluble factors, induced in viral-activated DCs, on endothelial permeability. Activated immune cells, including DC, secrete gelatinolytic matrix metalloproteases (gMMP-2 and -9) that modulate the vascular permeability for their trafficking.Methods: A clinical ANDES isolate was used to infect DC derived from primary PBMC. Maturation and pro-inflammatory phenotypes of ANDES-infected DC were assessed by studying the expression of receptors, cytokines and active gMMP-9, as well as some of their functional status. The ANDES-infected DC supernatants were assessed for their capacity to enhance a monolayer endothelial permeability using primary human vascular endothelial cells (HUVEC).Results: Here, we show thatin vitroprimary DCs infected by a clinical isolate of ANDV shed virus RNA and proteins, suggesting a competent viral replication in these cells. Moreover, this infection induces an enhanced expression of soluble pro-inflammatory factors, including TNF-α and the active gMMP-9, as well as a decreased expression of anti-inflammatory cytokines, such as IL-10 and TGF-β. These viral activated cells are less sensitive to apoptosis. Moreover, supernatants from ANDV-infected DCs were able to indirectly enhance the permeability of a monolayer of primary HUVEC.Conclusions: Primary human DCs, that are primarily targeted by hantaviruses can productively be infected by ANDV and subsequently induce direct effects favoring a proinflammatory phenotype of infected DCs. Finally, based on our observations, we hypothesize that soluble factors secreted in ANDV-infected DC supernatants, importantly contribute to the endothelial permeability enhancement that characterize the HCPS.

13 April 2021 in BMC Veterinary Research
Verified
Journal Article
Open access
PDF file
DNDeo Birungi Ndumu
Deo Birungi Ndumu
BBBakamutumaho Bakamutumaho
Bakamutumaho Bakamutumaho
EMEdward Miller
Edward Miller
JNJesca Nakayima
Jesca Nakayima
RDRobert Downing
Robert Downing
JGJean-Paul Gonzalez
Jean-Paul Gonzalez
Background: Prior to the first recorded outbreak of Rift Valley fever (RVF) in Uganda, in March 2016, earlier studies done until the 1970’s indicated the presence of the RVF virus (RVFV) in the country, without any recorded outbreaks in either man or animals. While severe outbreaks of RVF occurred in the neighboring countries, none were reported in Uganda despite forecasts that placed some parts of Uganda at similar risk. The Ministry of Agriculture, Animal Industry and Fisheries (MAAIF) undertook studies to determine the RVF sero-prevalence in risk prone areas. Three datasets from cattle sheep and goats were obtained; one from retrospective samples collected in 2010–2011 from the northern region; the second from the western region in 2013 while the third was from a cross-sectional survey done in 2016 in the south-western region. Laboratory analysis involved the use of the Enzyme Linked Immunosorbent Assays (ELISA). Data were subjected to descriptive statistical analyses, including non-parametric chi-square tests for comparisons between districts and species in the regions. Results: During the Yellow Fever outbreak investigation of 2010–2011 in the northern region, a total sero-prevalence of 6.7% was obtained for anti RVFV reacting antibodies (IgG and IgM) among the domestic ruminant population. The 2013 sero-survey in the western region showed a prevalence of 18.6% in cattle and 2.3% in small ruminants. The 2016 sero-survey in the districts of Kabale, Kanungu, Kasese, Kisoro and Rubirizi, in the south-western region, had the respective district RVF sero-prevalence of 16.0, 2.1, 0.8, 15.1and 2.7% among the domestic ruminants combined for this region; bovines exhibited the highest cumulative sero-prevalence of 15.2%, compared to 5.3 and 4.0% respectively for sheep and goats per species for the region. Conclusions: The absence of apparent outbreaks in Uganda, despite neighboring enzootic areas, having minimal restrictions to the exchange of livestock and their products across borders, suggest an unexpected RVF activity in the study areas that needs to be unraveled. Therefore, more in-depth studies are planned to mitigate the risk of an overt RVF outbreak in humans and animals as has occurred in neighboring countries.

24 July 2017 in European Journal of Lipid Science and Technology
Verified
Journal Article
Closed access
PDF file
ASAly Shamseddin
Aly Shamseddin
CCCéline Crauste
Céline Crauste
EDErwann Durand
Erwann Durand
PVPierre Villeneuve
Pierre Villeneuve
GDGregor Dubois
Gregor Dubois
FVFrancisco Veas
Francisco Veas

1 November 2019 in International Journal of Infectious Diseases
Verified
Journal Article
Open access
VLVivaldie Mikounou Louya
Vivaldie Mikounou Louya
CVChristevy Vouvoungui
Christevy Vouvoungui
FKFélix Koukouikila-Koussounda
Félix Koukouikila-Koussounda
FVFrancisco Veas
Francisco Veas
SKSimon Charle Kobawila
Simon Charle Kobawila
FNFrancine Ntoumi
Francine Ntoumi
Acute diarrhea is a leading cause of morbidity and mortality among children under five worldwide. As no published data is available on the occurrence of this infection in the Republic of Congo, this study aimed at (1) determining the prevalence and (2) characterizing genotypes of norovirus strains in Brazzaville. From June 2012 to June 2013, stool samples were collected from hospitalized young children with acute gastroenteritis. A total of 545 samples were tested for GI and GII norovirus infections using nested duplex reverse-transcription-polymerase chain reaction and sequencing. The GI and GII norovirus infection were detected in 148 samples. Males (28%) were not significantly more infected than females (25%). Norovirus infection was found exclusively in children aged under 24 months with a higher prevalence (P=0,048) in the age group of 7-12 months, and throughout the year with a peak in August and September. Genetic diversity of norovirus strains revealed that GII was the most prevalent (87%). No risk factor was significantly associated with norovirus infection. This study showed that noroviruses are important agents responsible for acute diarrhea in Congolese children and highlights the importance of continued surveillance.